Treatment of thrombotic thrombocytopenic purpura with the cryosupernatant fraction of plasma: A case report and review of the literature

American Journal of the Medical Sciences

Volumn 318, Issue 3, 1999, Pages 190-193

  Ellis, James ^a   Theodossiou, Chris ^a   Schwarzenberger, Paul ^a  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cryosupernatant; Plasmapheresis; Refractory thrombotic thrombocytopenic purpura (TTP)

Indexed keywords

FRESH FROZEN PLASMA;

ADULT; ARTICLE; CASE REPORT; FEMALE; HUMAN; PLASMAPHERESIS; SUPERNATANT; THROMBOTIC THROMBOCYTOPENIC PURPURA; TREATMENT FAILURE; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 0033499520     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9629(15)40612-3     Document Type: Article

References (31)

1. Moschcowitz E. An acute febrile pleiochromic anemia with hyaline thrombosis of the terminal arterioles and capillaries: an undescribed disease. Arch Intern Med 1925;36:294-310.
2. Moake JL. Thrombotic thrombocytopenic purpura. Thromb Haemost 1995;74:240-5.
3. Owens MR, Sweeney JD, Tahhan RH, et al. Influence of type of exchange fluid on survival in therapeutic apheresis for thrombotic thrombocytopenic purpura. J Clin Apheresis 1995;10:178-82.
4. Shumak KH, Rock GA, Nair RC, and the Canadian Apheresis Group. Late relapses in patients successfully treated for thrombotic thrombocytopenic purpura. Ann Int Med 1995;122:569-72.
5. Leaf AN, Laubenstein LJ, Raphael E, et al. Thrombotic thrombocytopenic purpura associated with immunodeficiency virus type 1 (HIV-1) infection. Ann Intern Med 1988; 109: 194-7.
6. Dixon AC, Kwock DW, Nakumura JM, et al. Thrombotic thrombocytopenic purpura and the human T-lymphotrophic virus, typel (HTLV-1). Ann Intern Med 1989;110:93-4.
7. Zeigler ZR, Shadduck RK, Nemunaitis J, et al. Bone marrow transplant-associated thrombotic microangiopathy: a case series. Bone Marrow Transplant 1995;15:247-53.
8. Gharpure VS, Devine SM, Holland HK, et al. Thrombotic thrombocytopenic purpura associated with FK 506 following bone marrow transplantation. Bone Marrow Transplant 1995;16:715-6.
9. Bukowski RM, Hewlett JS, Harris JW, et al. Exchange transfusions in the treatment of thrombotic thrombocytopenic purpura. Semin Hematol 1976;13:219-32.
10. Bukowski RM, King JW, and Hewlett JS. Plasmapheresis in the treatment of thrombotic thrombocytopenic purpura. Blood 1977;50:413-7.
11. Rose M, Rowe JM, and Eldor A. The changing course of thrombotic thrombocytopenic purpura and modern therapy. Blood Rev 1993;7:94-103.
12. Bell WR, Braine HG, Ness PM, et al. Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. N Engl J Med 1991;325:398-403.
13. Williams' hematology. 5th ed. Beutler E, editor. New York: McGraw-Hill; 1995.
14. Hayward CPM, Sutton DMC, Carter WH, et al. Treatment outcomes in patients with adult thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Arch Inter Med 1994;154:982-7.
15. Byrnes JJ, Moake JL, Klug P, et al. Effectiveness of the cryosupernatant fraction of plasma in the treatment of refractory thrombotic thrombocytopenic purpura. Am J Hematol 1990;34:169-74.
16. Moake JL, Byrnes JJ, Troll JH, et al. Effects of fresh frozen plasma and its cryosupernatant fraction on Von Willebrand factor multimeric forms in chronic relapsing thrombotic thrombocytopenic purpura. Blood 1985;65:1232-6.
17. Naumovski L, Pillsbury IIE. Treatment of thrombotic thrombocytopenic purpura with cryosupernatant [letter]. Am J Hematol 1991;38:250-1.
18. Obrador GT, Zeigler ZR, Shadduck RK, et al. Effectiveness of cryosupernatant therapy in refractory and chronic relapsing thrombotic thrombocytopenic purpura. Am J Hematol 1993;42:217-20.
19. Perotti C, Toretta L, Molinari E, et al. Cryoprecipitatepoor fraction (cryosupernatant) in the treatment of thrombotic thrombocytopenic purpura at onset. A report of four cases. Haematologica 1996;81:175-7.
20. Molinari E, Costamagna L, Perotti C, et al. Refractory thrombotic thrombocytopenic purpura: successful treatment by plasmapheresis with plasma cryosupernatant. Haematologica 1993;78:389-92.
21. Delgado-Lamas JL, Romero-Garcia F, and RodriguezCarrillo J. Treatment of thrombotic thrombocytopenic purpura using vincristine and factor VIII plasma free [letter]. Am J Hematol 1991;38:77.
22. Byrnes JJ, Khurana M. Treatment of thrombotic thrombocytopenic purpura with plasma. N Engl J Med 1977;297: 1386-9.
23. Miura M, Koizumi S, Nakamura K, et al. Efficacy of several plasma components in a young boy with chronic thrombocytopenia and hemolytic anemia who responds repeatedly to normal plasma infusions. Am J Hematol 1984;17: 307-19.
24. Rock GA, Shumak KH, Buskard NA, et al. Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. N Engl J Med 1991; 325:393-7.
25. Kelton JG, Moore J, Santos A, et al. Detection of a platelet-agglutinating factor in thrombotic thrombocytopenic purpura. Ann Int Med 1984;101:589-93.
26. Lian ECY, Harkness DR, Byrnes JJ, et al. Presence of a platelet aggregating factor in the plasma of patients with thrombotic thrombocytopenic purpura (TTP) and its inhibition by normal plasma. Blood 1979;53:333-8.
27. Moake JL, Rudy CK, Troll JH, et al. Unusually large plasma factor VIII: Von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura. N Engl J Med 1982;307:1432-5.
28. Asada Y, Sumiyoshi A, Hayashi T, et al. Immunohistochemistry of vascular lesion in thrombotic thrombocytopenic purpura, with special reference to factor VIII related antigen. Thrombosis Res 1985;38:469-72.
29. Kitchens CS. Studies of a patient with recurring thrombotic thrombocytopenic purpura. Am J Hematol 1982;13: 259-67.
30. Furlan M, Robles R, Solenthaler M, et al. Deficient activity of Von Willebrand factor-cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura. Blood 1997; 89:3097-103.
31. Button DM, Nair RC, and Rock G. Complications of plasma exchange. Transfusion 1989;29:124-7.